(Q57114558)

English

Pandemic influenza vaccine development: time is of the essence

article

In more languages

edit

Statements

0 references

0 references

Pandemic influenza vaccine development: time is of the essence (English)

0 references

1 reference

1 reference

2

Karl A Brokstad

0 references

Rebecca J Cox

series ordinal

1

object named as

Rebecca J Cox

0 references

author name string

Lars R Haaheim

series ordinal

3

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

Expert Review of Vaccines

0 references

volume

5

0 references

issue

5

0 references

page(s)

603-6

0 references

cites work

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14760584.5.5.603

retrieved

21 January 2018

Identifiers

DOI

10.1586/14760584.5.5.603

0 references

PubMed ID

17181432

0 references

(Q57114558)

Pandemic influenza vaccine development: time is of the essence

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)